Senseonics Holdings, Inc. current report, 26 January 2018

Business Context and Reporting Period

This Form 8-K Current Report was filed by Senseonics Holdings, Inc. on January 26, 2018. The filing reports on a material event occurring on the same date regarding the pricing of a registered underwritten public offering of debt securities.

Key Financial Metrics

The filing details the following capital raising metrics:

  • Instrument: 5.25% Convertible Senior Subordinated Notes due 2023.
  • Aggregate Principal Amount: $50.0 million.
  • Over-Allotment Option: Underwriters granted a 30-day option to purchase up to an additional $7.5 million in principal amount.
  • Expected Closing Date: On or about January 30, 2018.

The filing text does not provide specific values for revenue, profit, cash flow, operating margins, existing debt levels, or liquidity ratios. These metrics are not the subject of this specific current report.

Material Changes

The primary material change is the execution of the debt offering described above. This represents a new liability on the company's balance sheet upon closing. The filing does not provide comparative financial data against prior periods to quantify changes in operational performance.

Guidance, Outlook, and Risks

Management Commentary: The Company expects the Offering to close on or about January 30, 2018, subject to customary closing conditions. The filing incorporates by reference a press release and pricing term sheet regarding the transaction.

Risks and Contingencies: The report contains forward-looking statements regarding the timing of the closing and expected net proceeds. The Company disclaims any obligation to update these statements except as required by law. Actual results may differ materially due to risk factors detailed in the preliminary prospectus supplement (filed January 25, 2018), the 2016 Form 10-K, and the Q3 2017 Form 10-Q.

Investor Verification Checklist

  • Verify the final closing date and actual net proceeds received after underwriting discounts and expenses.
  • Review the preliminary prospectus supplement filed on January 25, 2018, for specific risk factors and use of proceeds.
  • Confirm the terms of the 30-day over-allotment option and whether it was exercised.
  • Assess the impact of the new 5.25% interest obligation on future cash flow and liquidity.